Delivery Order SPE2DB22D1103-SPE2DB25FTRR3

Award Date 7/11/25
Potential Completion Date 7/14/25
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, valued at $1,076.30, for the supply of the prescription drug Wegovy 2.4 mg/0.75 ml pen. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical products and medical supplies...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Wegovy 2.4 mg/0.75 ml pens. The contract has a ceiling value of $21,101.60 and runs through February 6, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,645.62 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Wegovy 2.4 mg/0.75 ml pens. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen Drug Corp to deliver pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,749.09, is for the delivery of Wegovy 2.4 mg/0.75 ml pens. The contract has a period of performance through June 26, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Wegovy 2.4 mg/0.75 ml pens. The contract has a ceiling value of $5,363.46 and a period of performance through April 11, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Wegovy 1.7 mg/0.75 ml pens. The contract has a ceiling value of $1,228.50 and a period of performance ending on May 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a $11,212.74 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 1.7 mg/0.75 ml pens, with a completion date of July 9, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,356.34, covers the delivery of Wegovy 2.4 mg/0.75 ml pen medication through January 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Wegovy 1.7 mg/0.75 ml pen 0.75 ml, a medication, with a ceiling value of $1,638.00 and a performance period through May 28, 2025. The contract is a firm fixed price, non-set-aside vehicle, meaning it was open to full and open competition. AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery Contract...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the supply of Wegovy 2.4 mg/0.75 ml pens with a ceiling value of $1,228.50 and a performance period through July 1, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTRR3
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the medical product Wegovy 2.4 mg/0.75 ml pen (0.75 ml). The contract, which does not have a set-aside designation, has a ceiling value of $3,312.36 and a performance period ending on July 14, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026, enabling the company to supply a wide range of medical products and supplies to various government agencies, particularly military and veteran healthcare systems.

Generated 10/12/25, 12:51 AM